Similar Articles
131 Risk factors for hepatocellular carcinoma in cirrhosis: A comprehensive analysis from a decade-long study
132 Nomogram model based on γ-glutamyl transferase to albumin ratio predicts survival in hepatocellular carcinoma patients with transarterial chemoembolization treatment
133 Matrine promotes colorectal cancer apoptosis by downregulating shank-associated RH domain interactor expression
134 Combinations of lenvatinib and immune checkpoint inhibitors plus transarterial chemoembolization, is it the prime time for unresectable hepatocellular carcinoma?
135 Advancing hepatocellular carcinoma treatment with hepatic arterial infusion chemotherapy
136 Current efficacy of hepatic arterial infusion chemotherapy in hepatocellular carcinoma
137 Multi-clustering study on the association between human leukocyte antigen-DP-DQ and hepatitis B virus-related hepatocellular carcinoma and cirrhosis in Viet Nam
138 Evaluating microvascular invasion in hepatitis B virus-related hepatocellular carcinoma based on contrast-enhanced computed tomography radiomics and clinicoradiological factors
139 Benefits and drawbacks of radiofrequency ablation via percutaneous or minimally invasive surgery for treating hepatocellular carcinoma
140 Unlocking the diagnostic potential of vascular endothelial growth factor and interleukin-17: Advancing early detection strategies for hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA